Terms: = Cervical cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
170 results:
1. Elevated INHBA Promotes Tumor Progression of cervical cancer.
Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
[No Abstract] [Full Text] [Related]
2. Investigation of in-vitro Anti-cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and cervical cancer Cell Lines.
Sharma V; Sinha ES; Singh J
Asian Pac J Cancer Prev; 2024 Feb; 25(2):575-585. PubMed ID: 38415544
[TBL] [Abstract] [Full Text] [Related]
3. Atractylodes macrocephala III suppresses emt in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H; Hu H; Hong Y
J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract] [Full Text] [Related]
5. Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the emt and cervical lymph node metastasis of oral squamous cell carcinoma.
Chien MH; Yang YC; Ho KH; Ding YF; Chen LH; Chiu WK; Chen JQ; Tung MC; Hsiao M; Lee WJ
Cell Death Dis; 2024 Jan; 15(1):82. PubMed ID: 38263290
[TBL] [Abstract] [Full Text] [Related]
6. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
7. cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
Wang J; Zhang B; Gong S; Liu Y; Yi L; Long Y
Int J Immunopathol Pharmacol; 2023; 37():3946320231223310. PubMed ID: 38131232
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
Fan Z; Sun X; Han X; Sun C; Huang D
Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
[TBL] [Abstract] [Full Text] [Related]
9. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and emt in cervical cancer.
Cheng Z; Wang H; Yang Z; Li J; Chen X
BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
[TBL] [Abstract] [Full Text] [Related]
10. HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
Wang P; Yang B; Huang H; Liang P; Long B; Chen L; Yang L; Tang L; Huang L; Liang H
AIDS Res Ther; 2023 Nov; 20(1):82. PubMed ID: 37981694
[TBL] [Abstract] [Full Text] [Related]
11. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
Deng Y; Dong Y; Wu L; Zhang Q; Yang L
Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
[TBL] [Abstract] [Full Text] [Related]
12. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
[TBL] [Abstract] [Full Text] [Related]
13. Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b
Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110967. PubMed ID: 37741126
[TBL] [Abstract] [Full Text] [Related]
14. miR-638 suppresses cervical cancer progression by inhibiting
Wang M; Liu K; Zhou Z; Geng H
Histol Histopathol; 2024 Apr; 39(4):497-509. PubMed ID: 37702425
[TBL] [Abstract] [Full Text] [Related]
15. Ginsenosides in endometrium-related diseases: Emerging roles and mechanisms.
Zhang YY; Li MZ; Shen HH; Abudukeyoumu A; Xie F; Ye JF; Xu FY; Sun JS; Li MQ
Biomed Pharmacother; 2023 Oct; 166():115340. PubMed ID: 37625321
[TBL] [Abstract] [Full Text] [Related]
16. Knockdown of miR-24 Suppressed the Tumor Growth of cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
He H; Lin C; Lu Y; Wu H
Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
[TBL] [Abstract] [Full Text] [Related]
17. EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
Sabanayagam R; Krishnamoorthy S; Gnanagurusamy J; Muruganatham B; Muthusami S
Med Oncol; 2023 Aug; 40(9):261. PubMed ID: 37544940
[TBL] [Abstract] [Full Text] [Related]
18. Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
Fang X; Hu P; Gao Y; Chen C; Xu J
Adv Clin Exp Med; 2024 Mar; 33(3):273-282. PubMed ID: 37486696
[TBL] [Abstract] [Full Text] [Related]
19. Circ_0001589/miR-1248/HMGB1 axis enhances emt-mediated metastasis and cisplatin resistance in cervical cancer.
Ma T; Guo J; Han J; Li L; Ren Y; Huang J; Diao G; Zheng X; Zheng Y
Mol Carcinog; 2023 Nov; 62(11):1645-1658. PubMed ID: 37431919
[TBL] [Abstract] [Full Text] [Related]
20. LINC00426, a novel m
Shen S; Jin H; Zhang X; Zhang Y; Li X; Yan W; Xie S; Yu B; Hu J; Liu H; Chen X; Nie Y; Liu F; Tang M; Gu Y; Wang S
Cell Signal; 2023 Sep; 109():110788. PubMed ID: 37392859
[TBL] [Abstract] [Full Text] [Related]
[Next]
